Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 139, Issue 1-2, 2003, Pages 76-80

  Ilyas, Amjad A ^a   Chen, Zie Wie ^a   Cook, Stuart D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Autoantibody; CSF; Multiple sclerosis; Sulfatide

Indexed keywords

ANTIBODY; MYELIN; SULFATIDE;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; THIN LAYER CHROMATOGRAPHY;

EID: 0038460068     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00131-0     Document Type: Article

References (30)

1. Acarin N., Rio J., Fernandez A.L., Tintore M., Duran I., Galan I., Montalban X. Differential antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol. Scand. 93:1996;99-103.
2. Arnon R., Crisp E., Kelley R., Ellison G.W., Myers L.W., Tourtellotte W.W. Anti-ganglioside antibodies in multiple sclerosis. J. Neurol. Sci. 46:1980;179-186.
3. Bansal R., Warrington A.E., Gard A.A.L., Ranscht B., Pfeiffer S.E. Multiple and novel specificities of monoclonal antibodies 01, 04, and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:1989;548-557.
4. Bansal R., Winkler S., Bheddah S. Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J. Neurosci. 19(18):1999;7913-7924.
5. Dyer C.A., Benjamins J.A. Galactocerebroside and sulfatide independently mediate Ca2+ responses in oligodendrocytes. J. Neurosci. Res. 30(4):1991;699-711.
6. Endo T., Scott D.D., Stewart S.S., Kundu S.K., Marcus D.M. Antibodies to glyco-sphingolipids in patients with multiple sclerosis and SLE. J. Immunol. 132:1984;1793-1797.
7. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
8. Ilyas A.A., Mithen F.A., Dalakas M.C., Wargo M., Chen Z.W., Bielroy L., Cook S.D. Antibodies to sulfated glycolipids in Guillain-Barré syndrome. J. Neurol. Sci. 105:1991;108-117.
9. Ilyas A.A., Mithen F.A., Dalakas M.C., Chen Z.W., Cook S.D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107:1992;111-121.
10. Ilyas A.A., Chen Z.-W., Prineas J.W. Generation and characterization of antibodies to sulfated glucuronyl glycolipids in Lewis rats. J. Neuroimmunol. 127:2002;54-58.
11. Karni A., Bakimer-Kleiner R., Abramsky O., Ben-Nun A. Elevated levels of antibody to myelin-oligodencyte glycoprotein is not specific for patients with multiple sclerosis. Arch. Neurol. 56:1999;311-315.
12. Kasai N., Pachner A.R., Yu R.K. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis. J. Neurol. Sci. 75:1986;33-42.
13. Kirschning E., Rutter G., Uhlig H., Dernick R. A sulfatide-reactive human monoclonal antibody obtained from a multiple sclerosis patient selectively binds to the surface of oligodendrocyte. J. Neuroimmunol. 56:1995;191-200.
14. Kolodny E.H., De Gasperi R., GamaSosa M.A., Weinreb H.J., Herbert J. Antisulfatide immunoglobulin G is elevated in the serum of multiple sclerosis patients. Ann. Neurol. 38:1995;340.
15. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 7:2001;115-121.
16. Mata S., Lolli F., Soderstrom M., Pinto F., Link H. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Mult. Scler. 5(6):1999;379-388.
17. Moller J.R., Johnson D., Brady R.O., Tourtellotte W.W., Quarles R.H. Antibodies to myelin-associated glycoprotein glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 22:1989;55-61.
18. Noseworthy J.H., Lucchinetti C., Rodriguez M., Weinshenker B.G. Multiple sclerosis. New Engl. J. Med. 343:2000;938-952.
19. Prineas J.W., Connell F. Remyelination in multiple sclerosis. Ann. Neurol. 5:1979;22-54.
20. Prineas J.W., Kwon E.E., Goldenberg P.Z., Ilyas A.A., Quarles R.H., Benjamin J.A., Sprinke T.J. Multiple sclerosis: oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61:1989;489-503.
21. Raine C.S., Cannella B., Haauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen specific antibody mediation. Ann. Neurol. 4:1999;144-160.
22. Ryberg B. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy. J. Neurol. Sci. 38:1978;357-382.
23. Sadatipour B.T., Greer J.M., Pender M.P. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann. Neurol. 44:1998;980-983.
24. Sellebjerg F.T., Frederiksen J.L., Olsson T. Anti-myelin basic protein and proteolipid protein antibody secreting cells in the cerebrospinal fluid of patients with optic neuritis. Arch. Neurol. 51:1994;1032-1036.
25. Sharief M.K., Keir G., Thompson E.J. Intrathecal synthesis of IgM in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation. J. Neurol. Sci. 96:1990;131-142.
26. Stevens A., Weller M., Wietholter H. CSF and serum ganglioside antibodies in MS. Acta Neurol. Scand. 6(5):1992;485-489.
27. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transaction in the lesions of multiple sclerosis. New Engl. J. Med. 338:1998;278-285.
28. Villar, L.M., Masjuan, J., Gonzalez-Porque, P., Plaza, J., Sadaba, M.C., Roldan, E., Bootello, A., Alvarez-Cermeno, J.C., 2002. Intrathecal IgM synthesis in neurological diseases: relationship to disability in MS. Neurology 12, 58(5), 824-826.
29. Warren K.G., Catz I. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid. J. Neurol. Sci. 121:1994;66-73.
30. Xiao B.-G., Linington C., Link H. Antibodies to myelin-oligodendroglial glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:1991;91-96.